WallStreetZenWallStreetZen

NASDAQ: EPRX
Eupraxia Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for EPRX

Based on 2 analysts offering 12 month price targets for Eupraxia Pharmaceuticals Inc

Min Forecast
$11.00+39.42%
Avg Forecast
$15.00+90.11%
Max Forecast
$19.00+140.81%

Should I buy or sell EPRX stock?

Based on 2 analysts offering ratings for Eupraxia Pharmaceuticals Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although EPRX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates EPRX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their EPRX stock forecasts and price targets.

EPRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-22
lockedlocked$00.00+00.00%2026-01-15Find Out Why

1 of 1

EPRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EPRX$7.89$15.00+90.11%Strong Buy
LRMR$3.94$13.50+242.64%Strong Buy
BNTC$11.95$27.00+125.94%Buy
VNDA$7.00$15.88+126.79%Strong Buy
IPSC$2.31$3.67+58.74%Buy
View Top Biotech Stocks

Eupraxia Pharmaceuticals Stock Forecast FAQ

Is Eupraxia Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: EPRX) stock is to Strong Buy EPRX stock.

Out of 2 analysts, 1 (50%) are recommending EPRX as a Strong Buy, 1 (50%) are recommending EPRX as a Buy, 0 (0%) are recommending EPRX as a Hold, 0 (0%) are recommending EPRX as a Sell, and 0 (0%) are recommending EPRX as a Strong Sell.

If you're new to stock investing, here's how to buy Eupraxia Pharmaceuticals stock.

What is EPRX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year EPRX price target, the average EPRX price target is $15.00, with the highest EPRX stock price forecast at $19.00 and the lowest EPRX stock price forecast at $11.00.

On average, Wall Street analysts predict that Eupraxia Pharmaceuticals's share price could reach $15.00 by Apr 22, 2027. The average Eupraxia Pharmaceuticals stock price prediction forecasts a potential upside of 90.11% from the current EPRX share price of $7.89.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.